Sign up to save your podcasts
Or
Share Life Science Today 012 – Probiotics, Lipid Nanoparticles, Transparency, and Immuno-therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Life Science Today 012 – Probiotics, Lipid Nanoparticles, Transparency, and Immuno-therapy
Originally Published as The Niche Podcast
Finch does probiotics the expensive way, lipid nanoparticles, a followup on transparency, and LAVA gains immuno-therapy support.
Sponsors
https://www.thescopemethod.com
Story References
https://www.businesswire.com/news/home/20200916005915/en/Moderna-and-Vertex-Establish-New-Collaboration-to-Treat-Cystic-Fibrosis-Using-Gene-Editing
https://finchtherapeutics.com/blog/finch-therapeutics-announces-90-million-financing
https://www.modernatx.com/sites/default/files/mRNA-1273-P301-Protocol.pdf
https://www.businesswire.com/news/home/20200916005913/en/LAVA-Therapeutics-Announces-83-million-Series-C-Financing-to-Advance-Novel-Immuno-Oncology-Programs
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
View all episodes
By Noah Goodson, PhD
5
77 ratings
Originally Published as The Niche Podcast
Finch does probiotics the expensive way, lipid nanoparticles, a followup on transparency, and LAVA gains immuno-therapy support.
Sponsors
https://www.thescopemethod.com
Story References
https://www.businesswire.com/news/home/20200916005915/en/Moderna-and-Vertex-Establish-New-Collaboration-to-Treat-Cystic-Fibrosis-Using-Gene-Editing
https://finchtherapeutics.com/blog/finch-therapeutics-announces-90-million-financing
https://www.modernatx.com/sites/default/files/mRNA-1273-P301-Protocol.pdf
https://www.businesswire.com/news/home/20200916005913/en/LAVA-Therapeutics-Announces-83-million-Series-C-Financing-to-Advance-Novel-Immuno-Oncology-Programs
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.